| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 12.3% | 12.3% | ● 0.0% |
| IT - Software | 7.5% | 6.7% | ▼ -0.8% |
| Pharmaceuticals & Biotechnology | 4.7% | 4.6% | ▼ -0.1% |
| Telecom - Services | 3.9% | 4.0% | ▲ +0.1% |
| Finance | 3.0% | 3.8% | ▲ +0.7% |
| Construction | 3.4% | 3.7% | ▲ +0.4% |
| Automobiles | 3.7% | 3.5% | ▼ -0.2% |
| Power | 3.0% | 3.4% | ▲ +0.5% |
| Insurance | 2.7% | 2.9% | ▲ +0.2% |
| Petroleum Products | 3.5% | 2.9% | ▼ -0.5% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Banks | 12.3% | 12.7% | ▲ +0.4% |
| IT - Software | 6.7% | 6.8% | ● +0.0% |
| Pharmaceuticals & Biotechnology | 4.6% | 5.0% | ▲ +0.4% |
| Telecom - Services | 4.0% | 4.4% | ▲ +0.3% |
| Construction | 3.7% | 3.8% | ● +0.0% |
| Finance | 3.8% | 3.8% | ● +0.0% |
| Automobiles | 3.5% | 3.5% | ● +0.1% |
| Insurance | 2.9% | 3.3% | ▲ +0.3% |
| Power | 3.4% | 3.2% | ▼ -0.2% |
| Diversified FMCG | 2.5% | 2.6% | ● +0.0% |
Comparing Apr 2026 → May 2026
| # | Stock | Sector | Weight (May 2026) |
|---|---|---|---|
| 1 | Alembic Pharmaceuticals Limited ₹20.54 Cr |
Pharmaceuticals & Biotechnology | 0.32% |
| # | Stock | Sector | Last Weight (Apr 2026) |
|---|---|---|---|
| 1 | Nippon Life India Asset Management Limited ₹25.03 Cr |
Capital Markets | 0.38% |
| # | Stock | Sector | Apr 2026 | May 2026 | Change |
|---|---|---|---|---|---|
| 1 | HDFC Bank Limited ₹346.77 Cr |
Banks | 4.86% | 5.36% | +0.50% |
| 2 | Infosys Limited ₹214.63 Cr |
IT - Software | 3.10% | 3.32% | +0.22% |
| 3 | Bharti Airtel Limited ₹187.81 Cr |
Telecom - Services | 2.69% | 2.90% | +0.21% |
| 4 | Marksans Pharma Limited ₹54.60 Cr |
Pharmaceuticals & Biotechnology | 0.66% | 0.84% | +0.18% |
| 5 | Grasim Industries Limited ₹75.04 Cr |
Cement & Cement Products | 0.99% | 1.16% | +0.17% |
| 6 | ICICI Prudential Life Insurance Company Limited ₹48.12 Cr |
Insurance | 0.58% | 0.74% | +0.16% |
| 7 | Caplin Point Laboratories Limited ₹58.36 Cr |
Pharmaceuticals & Biotechnology | 0.76% | 0.90% | +0.14% |
| 8 | Indus Towers Limited ₹93.56 Cr |
Telecom - Services | 1.33% | 1.45% | +0.12% |
| 9 | Shivalik Bimetal Controls Ltd ₹40.01 Cr |
Industrial Products | 0.51% | 0.62% | +0.11% |
| 10 | Biocon Limited ₹39.35 Cr |
Pharmaceuticals & Biotechnology | 0.51% | 0.61% | +0.10% |
| # | Stock | Sector | Apr 2026 | May 2026 | Change |
|---|---|---|---|---|---|
| 1 | Vedanta Limited ₹28.75 Cr |
Diversified Metals | 0.74% | 0.44% | -0.30% |
| 2 | Glenmark Pharmaceuticals Limited ₹30.29 Cr |
Pharmaceuticals & Biotechnology | 0.73% | 0.47% | -0.26% |
| 3 | EQ - NIIT LEARNING SYSTEMS LTD ₹43.50 Cr |
Other Consumer Services | 0.90% | 0.67% | -0.23% |
| 4 | Bharat Petroleum Corporation Limited ₹91.14 L |
Petroleum Products | 0.24% | 0.01% | -0.23% |
| 5 | Mphasis Limited ₹8.75 Cr |
IT - Software | 0.36% | 0.14% | -0.22% |
| 6 | Reliance Industries Limited ₹161.44 Cr |
Petroleum Products | 2.68% | 2.49% | -0.19% |
| 7 | Power Grid Corporation of India Limited ₹132.66 Cr |
Power | 2.23% | 2.05% | -0.18% |
| 8 | State Bank of India ₹97.78 Cr |
Banks | 1.66% | 1.51% | -0.15% |
| 9 | Aurobindo Pharma Limited ₹68.49 Cr |
Pharmaceuticals & Biotechnology | 1.20% | 1.06% | -0.14% |
| 10 | The Great Eastern Shipping Company Limited ₹43.34 Cr |
Transport Services | 0.79% | 0.67% | -0.12% |
61 stocks — May 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹346.77 Cr |
Banks |
5.36%
|
|
| 2 |
₹278.75 Cr |
Banks |
4.31%
|
|
| 3 |
₹214.63 Cr |
IT - Software |
3.32%
|
|
| 4 |
₹189.07 Cr |
Construction |
2.92%
|
|
| 5 |
₹187.81 Cr |
Telecom - Services |
2.90%
|
|
| 6 |
₹166.02 Cr |
Diversified FMCG |
2.56%
|
|
| 7 |
₹161.44 Cr |
Petroleum Products |
2.49%
|
|
| 8 |
₹132.66 Cr |
Power |
2.05%
|
|
| 9 |
₹132.61 Cr |
IT - Software |
2.05%
|
|
| 10 |
₹101.73 Cr |
Finance |
1.57%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.